Weighing Out The Risks of GLP-1 Receptor Agonists with Emily Ruths

In this engaging episode, Emily Ruths discusses the complexities of GLP-1 receptor agonists, focusing on their risks and benefits. She shares her personal journey in accessing these medications and provides insights into how conditions like PCOS affect individuals. The conversation highlights the differences between compounded and brand-name versions of GLP-1 drugs, her experiences with negative side effects, and how her food consumption has evolved. Emily ties her insights back to her background in healthcare, offering a well-rounded perspective on the topic.